On March 13, 2020, Governor Greg Abbott declared a state of disaster for all Texas Counties as a result of the COVID-19 (coronavirus) pandemic. In planning for the agency's response, the health and safety of the public and of our employees is of utmost concern. The offices of the Texas State Board of Pharmacy are open and operational, and we will continue to perform the essential functions of our agency while providing the highest level of service possible. Please note that many agency employees are working remotely. The best way to contact the office is by email. A list of agency emails can be found here.

• 

  Pharmacists

  Apply
  Renew or Update
  Print Your Certificate
  
• 

  Interns

  Apply
  Print Your Certificate
  
• 

  Pharmacies

  Apply
  Renew or Update
  
• 

  Technicians

  Apply
  Renew or Update
  Print Your Certificate
  Duties
  

Updates, News & Notices     Visit TSBP Newsroom

	DEA Take Back Day — April 24, 2021 The Drug Enforcement Administration's (DEA) next National Prescription Drug Take Back Day will be held on April 24, 2021 from 10am to 2pm. Learn more about the DEA's National Prescription Drug Take Back Day, locate collection sites, and access additional resources on DEA's website here: ▸ DEA Take Back Day April 9, 2021		Podcast Launch — TSBP Talks TSBP has launched a new podcast to bring you Board news and updates. Listen to our first episode here: ▸ TSBP Talks April 9, 2021
	Scam Alert Notice — UPDATE: April 2021 TSBP continues to receive reports of scams involving individuals impersoning state agency entities. The most recent scam reports to TSBP indicate instances of telephone scammers spoofing TSBP's phone number so that the calls appear to be originating from TSBP directly. Remember that TSBP staff does NOT request your personal information in unsolicited phone calls. TSBP will NEVER request money or bank account information in a phone call. You may report information on telephone scammers to the Texas OAG. ▸ Read the Texas OAG release regarding these types of scams ▸ Learn more about reporting scammers ▸ Click here to see an example scam letter April 7, 2021		Compounding Advisory Group to Discuss FDA MOU in June 2021 - Stakeholder Input Requested The Board discussed the U.S. Food and Drug Administration (FDA) Memorandum of Understanding (MOU) at the February 2021 Board meeting and voted to add the MOU to the Compounding Advisory Group agenda at their upcoming meeting in June 2021. The upcoming Compounding Advisory Group meeting will elicit input from stakeholders regarding the MOU, and together with stakeholder input provide a recommendation to the Board for consideration at the August 2021 Board meeting. Compounding Advisory Group schedules and agendas are posted here as they become available: ▸ Compounding Advisory Group schedule & agenda information February 25, 2021

Additional Important Information

• Recognizing Nontherapeutic Dispensing or ("Pill Mill" Activity)
• Notification of Temporary Suspensions
• Pharmacists Authorized to Sign Prescriptions When Performing Drug Therapy Management Under Protocol
• Information Regarding Controlled Substances
• Patient Safety Reminder